Amgen Inc.
Growth differentiation factor 15 (GDF-15) constructs
Last updated:
Abstract:
Constructs comprising GDF15, and mutants thereof are provided. In various embodiments the constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Status:
Grant
Type:
Utility
Filling date:
29 Nov 2017
Issue date:
19 Jan 2021